In an interview with the Wall Street Journal, Oberton and Hologic CEO Steve MacMillan — who together rode a wave of “COVID cash” from the company’s diagnostics business during the pandemic — discussed how they kept employment steady even as test sales slowed.
The Hologic’s leadership team formed its “philosophy that mass layoffs are a failure of leadership” even before the pandemic, Oberton said.
With nearly $4.9 billion in annual sales, Hologic is the world’s 26th-largest medical device manufacturer, according to Medical Design & Outsourcing‘s Medtech Big 100 ranking by revenue.
That Medtech Big 100 ranking also tracks employment over time. Hologic repor…